---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-23-000058"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2023-08-15T23:59:59+00:00"
generated_at: "2026-06-11T09:46:10.493273+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health Q4 non-GAAP EPS $1.55 (+48%); raises FY24 guidance to $6.50-$6.75

## Summary
- Q4 revenue $53.5B (+13% YoY); non-GAAP EPS $1.55 (+48%) vs $1.05 prior year.
- Pharmaceutical segment profit up 12% to $504M; Medical segment profit improved to $82M from -$16M.
- Full-year non-GAAP EPS $5.79 (+14%), an all-time high; operating cash flow $2.8B.
- FY2024 non-GAAP EPS guidance raised to $6.50-$6.75 from $6.45-$6.70; segment profit growth expected.
- Director Carrie S. Cox will not stand for re-election at 2023 annual meeting; no disagreement.

## SEC filing metadata
- accession: 0000721371-23-000058
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2023-08-15T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137123000058/0000721371-23-000058-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137123000058/cah-20230810.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-23-000058
- JSON: https://secwatch.observer/filing/0000721371-23-000058.json
- Plain text: https://secwatch.observer/filing/0000721371-23-000058.txt

## Key facts
- Earnings Releases
  CARDINAL HEALTH INC reported the quarter and fiscal year ended June 30, 2023 results: revenue $205.0 billion, net income $261 million, EPS $1.00. Guidance raised.
  - Period: the quarter and fiscal year ended June 30, 2023
  - Revenue: $205.0 billion
  - Net income: $261 million
  - EPS: $1.00
  - Guidance: raised
  - Result: reported results
  source text: RELEASE Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2023 at High End of Investor Day Guidance • Fourth quarter revenue increased 13% to $53.5 billion • Fourth quarter GAAP 1 operating earnings were $137 million and GAAP diluted loss per share was $0.25 • Fourth quarter non-GAAP operating earnings increased 24% to $560 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/721371/000072137123000058/0000721371-23-000058-index.htm
- Earnings Releases
  CARDINAL HEALTH INC reported the quarter and fiscal year ended June 30, 2023 results: revenue $205.0 billion, net income $261 million, EPS $1.00. Guidance raised.
  - Period: the quarter and fiscal year ended June 30, 2023
  - Revenue: $205.0 billion
  - Net income: $261 million
  - EPS: $1.00
  - Guidance: raised
  - Result: reported results
  source text: Fiscal year 2023 revenues were $205.0 billion
  evidence_url: https://www.sec.gov/Archives/edgar/data/721371/000072137123000058/0000721371-23-000058-index.htm
- Executive change
  Carrie S. Cox departed as Director at CARDINAL HEALTH INC.
  - Action: decided not to stand for re-election
  - Role: Director
  source text: On August 10, 2023, Carrie S. Cox, a member of the Board of Directors (the “Board”) of the Company since 2009, informed the Company that she has decided not to stand for re-election to the Board when her term expires at the 2023 annual meeting of shareholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/721371/000072137123000058/0000721371-23-000058-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.